The Benign Prostatic Hyperplasia (BPH) Treatment Market was valued at USD 1.57 billion in 2023 and is projected to reach USD 3.38 billion by 2032, growing at a CAGR of 8.92% over the forecast per...
Posted by Bhavana on August 08 2024 at 12:34 PM
public
The global benign prostatic hyperplasia (bph) treatment market size was valued at USD 11.6 million in 2023 and is poised to grow at a significant CAGR of 5.6% during the forecast period 2024-2030...